reproductive safety information - MGH Center for Women's Mental Health

United Kingdom Limits the Use of Valproate in Reproductive Age Women

Last year France banned the use of the antiepileptic during valproate in certain populations of reproductive age women. Now the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) has banned the use of [...]

By MGH Center for Women's Mental Health|2018-09-10T12:34:17-04:00May 9th, 2018|Antiepileptic Drugs, Bipolar Disorder|0 Comments

New Research from the CWMH: Complementary Therapies Commonly Taken by Pregnant Women with Psychiatric Illness

When I recently reviewed the stats for our website, I was surprised when I looked at the most frequently visited posts. I was expecting to find at the top of the list one of our [...]

By MGH Center for Women's Mental Health|2020-11-26T08:37:01-04:00March 28th, 2016|Psychiatric Disorders During Pregnancy|0 Comments

FDA’s New Labeling Rule: Clinical Implications

The following post was first published in OB/GYN News.

By MGH Center for Women's Mental Health|2015-05-01T12:02:29-04:00January 28th, 2015|Breastfeeding and Psychiatric Medications, Psychiatric Disorders During Pregnancy|0 Comments